LNAI earnings date and last-quarter result: P/E -0.04. Updated 2026-07-23.
Lunai Bioworks (LNAI) Research Hub
Lunai Bioworks (LNAI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.275 USD (-6.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.04, market cap 0.01B. This hub links to the full technical, earnings and options research available for LNAI.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.275 USD (-6.65%) |
| 52-week range | 0.2265 USD – 5.02 USD |
| Trend regime | Range |
| 14-day RSI | 15.2 (Oversold) |
| Trailing P/E | -0.04 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for LNAI
Covered Call on LNAI: how it works, illustrative setup around the real 0.275 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LNAI: how it works, illustrative setup around the real 0.275 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LNAI: how it works, illustrative setup around the real 0.275 USD price, max profit/loss, breakeven and when to use it. Educational.
LNAI technical analysis: range, last 0.275 USD, RSI 15.2, 52w range 0.2265 USD–5.02 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is LNAI in?
Lunai Bioworks (LNAI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is LNAI in an uptrend or downtrend?
As of 2026-10-26, LNAI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LNAI's trailing P/E ratio?
LNAI's trailing P/E is -0.04, with a market cap of 0.01B. See the earnings research page for full valuation detail.